Shan, Xingli
Bai, Hongsong
Ning, Houshan
Xie, Chengming
Chen, Yonghai
Xing, Sijia
Ni, Donglin
Guo, Xiaohua
Zeng, Jingke https://orcid.org/0000-0002-9874-888X
Hu, Linjun https://orcid.org/0000-0003-1449-9626
Article History
Received: 28 August 2025
Revised: 20 November 2025
Accepted: 3 December 2025
First Online: 26 December 2025
Ethics approval and consent to participate
: The study protocol was approved by the Ethics Committee of Beijing Chaoyang Huanxing Cancer Hospital (approval no. 2020-10), and the study was conducted following the Declaration of Helsinki, Good Clinical Practice Guidelines, and Chinese regulatory requirements. Written informed consent was obtained from all patients.
: The authors declare no competing interests.
: Not applicable.